interferon beta (PBL Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinterferon beta (PBL Therapeutics)
Drug Alias NameIFN beta (PBL Therapeutics)multiple sclerosis therapy (PBL Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWorld
CombinationsNo
Global Highest StatusSuspended
Highest Status in ChinaN/A
Originator CompaniesPBL Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesPBL Therapeutics
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A